SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer.
The article focuses on SPRINTR (Swedish PRecision medicine Initiative for Novel Treatments and Research), a national research infrastructure established to enhance precision medicine in prostate cancer through efficient recruitment and biomarker-driven clinical trials. SPRINTR integrates molecular p...
| Publicado en: | Acta Oncologica Vol. 65; pp. 375 - 379 |
|---|---|
| Autores principales: | , |
| Formato: | letter pictorial tables/charts Journal Article |
| Publicado: |
Medical Journals Sweden AB
2026 Special Issue
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=193700261&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 193700261 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0284186X B84 jtl: Acta Oncologica issn: 0284186X maglogo: N pubinfo: dt: 2026 Special Issue vid: 65 pid: 59195 pub: Medical Journals Sweden AB artinfo: ui: 193700261 193700261 193700261 10.2340/ao.v65.45126 193700261 ppf: 375 ppct: 4 formats: tig: atl: SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer. aug: au: Welén, Karin Josefsson, Andreas affil: Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden sug: subj: Prostatic Neoplasms Therapy Patient Selection Clinical Trials Research Subject Recruitment Medicine Biological Markers Gene Expression Profiling Molecular Imaging Clinical Trial Registry Health Information Systems Comorbidity Neoplasm Staging ab: The article focuses on SPRINTR (Swedish PRecision medicine Initiative for Novel Treatments and Research), a national research infrastructure established to enhance precision medicine in prostate cancer through efficient recruitment and biomarker-driven clinical trials. SPRINTR integrates molecular profiling, clinical data, and patient consent into routine diagnostic workflows across Sweden, creating a study-ready population for multiple research purposes including diagnosis, prognosis, treatment prediction, quality of life, and health economics. The platform supports standardized biomarker analysis, centralized data management, and broad ethical approval, enabling scalable, nationwide participation and facilitating equitable patient access to clinical trials. SPRINTR aligns with national and international precision medicine initiatives to accelerate biomarker validation and improve outcomes for men with prostate cancer. pubtype: Academic Journal doctype: letter pictorial tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|